首站-论文投稿智能助手
典型文献
肺肉瘤样癌术后迅速多发转移行免疫联合治疗1例
文献摘要:
肺肉瘤样癌(pulmonary sarcomatoid carcinoma,PSC)是一种少见、分化较差的非小细胞肺癌(non-small cell lung cancer,NSCLC),手术根治切除是早期主要的有效治疗手段,中期能切除者以手术切除为主的综合治疗,不能切除者以根治性放化疗为主,对于晚期则根据肿瘤病理类型及基因检测的结果制定个体化的全身治疗方案.目前的大多数研究表明PSC患者的预后比其余的NSCLC患者更差.随着分子检测技术在临床的广泛应用,发现69%~80%PSC患者包含至少一个基因突变.本文为陕西省人民医院肿瘤内科收治的PSC术后迅速多发转移患者,通过基因检测指导治疗,患者获得较明显的缓解,报道其诊疗过程以期为PSC治疗提供临床参考.
文献关键词:
肺肉瘤样癌;免疫治疗;靶向治疗
作者姓名:
蒋振江;张媛;李东辉
作者机构:
西安医学院,西安710021;陕西省人民医院肿瘤内科,西安710068
文献出处:
引用格式:
[1]蒋振江;张媛;李东辉-.肺肉瘤样癌术后迅速多发转移行免疫联合治疗1例)[J].循证医学,2022(03):187-192
A类:
B类:
肺肉瘤样癌,多发转移,移行,免疫联合治疗,pulmonary,sarcomatoid,carcinoma,PSC,非小细胞肺癌,small,cell,lung,cancer,NSCLC,治疗手段,手术切除,综合治疗,根治性放化疗,肿瘤病,病理类型,基因检测,全身治疗,分子检测技术,基因突变,陕西省人民医院,肿瘤内科,免疫治疗,靶向治疗
AB值:
0.323543
相似文献
初始不可切除IIIB期非小细胞肺癌免疫联合化疗后的根治性微创手术
Hongsheng DENG;Jun LIU;Xiuyu CAI;Jiawei CHEN;Gaetano ROCCO;Rene'Horsleben PETERSEN;Alessandro BRUNELLI;Calvin S.H.NG;Thomas A. D'AMICO;Wenhua LIANG;Jianxing HE;雷杰-Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China;Department of General Internal Medicine, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China;Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY;Department of Cardiothoracic Surgery, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark;Department of Thoracic Surgery, St. James's University Hospital, Leeds, UK;Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong SAR, China;Division of Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC;空军军医大学第二附属医院胸腔外科,西安 710000
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。